Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia
Brotchie, Jonathan M.
Crossman, Alan R.
MetadataShow full item record
AbstractThe classic view of anatomofunctional organization of the basal ganglia is that striatopallidal neurons of the “indirect” pathway express D2 dopamine receptors and corelease enkephalin with GABA, whereas striatopallidal neurons of the “direct” pathway bear D1 dopamine receptors and corelease dynorphin and substance P with GABA. Although many studies have investigated the pathophysiology of the basal ganglia after dopamine denervation and subsequent chronic levodopa (l-dopa) treatment, none has ever considered the possibility of plastic changes leading to profound reorganization and/or biochemical phenotype modifications of medium spiny neurons. Therefore, we studied the phenotype of striatal neurons in four groups of nonhuman primates, including the following: normal, parkinsonian, parkinsonian chronically treated with l-dopa without exhibiting dyskinesia, and parkinsonian chronically treated with l-dopa exhibiting overt dyskinesia. To identify striatal cells projecting to external (indirect) or internal (direct) segments of the globus pallidus, the retrograde tracer cholera toxin subunit B (CTb) was injected stereotaxically into the terminal areas. Using immunohistochemistry techniques, brain sections were double labeled for CTb and dopamine receptors, opioid peptides, or the substance P receptor (NK1). We also used HPLC-RIA to assess opioid levels throughout structures of the basal ganglia. Our results suggest that medium spiny neurons retain their phenotype because no variations were observed in any experimental condition. Therefore, it appears unlikely that dyskinesia is related to a phenotype modification of the striatal neurons. However, this study supports the concept of axonal collateralization of striatofugal cells that project to both globus pallidus pars externa and globus pallidus pars interna. Striatofugal pathways are not as segregated in the primate as previously considered.
CitationNadjar A, Brotchie J, Guigoni C, Li Q, Zhou S, Wang G, Ravenscroft P, Georges F, Crossman A, Bezard E (2006) 'Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia', Journal of Neuroscience, 26 (34), pp.8653-8661.
PublisherSociety for Neuroscience
JournalJournal of Neuroscience
PubMed Central IDPMC6674386
- Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.
- Authors: Guigoni C, Doudnikoff E, Li Q, Bloch B, Bezard E
- Issue date: 2007 May
- Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
- Authors: Betarbet R, Greenamyre JT
- Issue date: 2004 Oct
- L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
- Authors: Suárez LM, Solís O, Caramés JM, Taravini IR, Solís JM, Murer MG, Moratalla R
- Issue date: 2014 May 1
- Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.
- Authors: Perez XA, Zhang D, Bordia T, Quik M
- Issue date: 2017 Apr
- The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
- Authors: Robertson RG, Clarke CA, Boyce S, Sambrook MA, Crossman AR
- Issue date: 1990 Oct 29